Recist (response Evaluation Criteria In Solid Tumors) - Histology

Relevant Publications

Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma.

Issue Release: 2024

Multifrequency Magnetic Resonance Elastography Detects Small Abdominal Lymph Node Metastasis by High Stiffness.

Issue Release: 2024

Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.

Issue Release: 2024

Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: Challenges and new insights.

Issue Release: 2024

A Neuroradiologist\'s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.

Issue Release: 2024

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.

Issue Release: 2024

Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.

Issue Release: 2024

Assessing Radiological Response to Immunotherapy in Lung Cancer: An Evolving Arena.

Issue Release: 2024

PET/Computed Tomography Transformation of Oncology: Immunotherapy Assessment.

Issue Release: 2024

Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors.

Issue Release: 2024

Role of Cyclin-Dependent Kinase 4/6 in Metastatic Breast Cancer: Real-World Data From a Tertiary Care Institute in Eastern India.

Issue Release: 2024

Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial.

Issue Release: 2024

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.

Issue Release: 2024

[Multiparametric magnetic resonance imaging for hepatocellular carcinoma, part 1 : Morphology and dynamic perfusion imaging in primary diagnostics and treatment monitoring].

Issue Release: 2024

Optimal cut-off value for identifying objective response in patients with nasopharyngeal carcinoma after induction chemotherapy.

Issue Release: 2024

Prediction of Microwave Ablation Recurrence in Pulmonary Malignancies Using Preoperative Computed Tomography Radiomics Models.

Issue Release: 2024

Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3).

Issue Release: 2024

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

Issue Release: 2024

Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma.

Issue Release: 2024

Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.

Issue Release: 2024

What Techniques are Used for Data Segmentation in Histology?

Why is Chemiluminescence Preferred over Other Detection Methods?

Why is Vacuum Used in Histology?

Which Parasitic Infections Involve Trophozoites?

What is the Role of Calcium in Cellular Functions?

What is the Basic Structure of a Cell?

What Are the Benefits of Using Digital Records?

How is Quality Assessed?

How Can Automation Help Reduce Variability?

What Techniques are Used to Study Apaf-1 in Histology?

Recist (response Evaluation Criteria In Solid Tumors) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics